Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aphria Inc. APHA

Healthcare Drug Manufacturers - Major Cannabis
Aphria, which is headquartered in Ontario, produces and sells medicinal and recreational cannabis. The company operates through retail and wholesale channels in Canada and internationally. Aphria is a main distributor of medical cannabis to Germany and has operations in over 10 countries outside of Canada. However, it does not have exposure to the U.S. CBD or THC markets due to the constraints of federal prohibition. It has some U.S. exposure through the acquisition of SweetWater, a craft brewer


NDAQ:APHA - Post by User

Aphria Inc.
Bullboard Posts
User Avatar Image
(0)
•••
Comment by Bobthebuilddron Jan 12, 2017 1:12pm
72 Views
Post# 25700106

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Good News = SP drop??

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Good News = SP drop??There good and follow the industry rules better then anyone. The issue with THC is there management is pretty bad at Investor relations or publishing what there doing. There NR are vague AF. But showing profit when they couldn't even sell MJ yet is crazy good.
CanadianJrs wrote: Only reason anyone would buy THC is for the licenses and the health Canada approved lab. Their business model isn't capitalist friendly. I got in at $0.10 there and traded it all the way up to $1.08. Made a killing off that company but I won't be buying back in in the near future. 


Bullboard Posts
Dealroom for high-potential pre-IPO opportunities